Jinyu Lu

836 total citations
21 papers, 670 citations indexed

About

Jinyu Lu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jinyu Lu has authored 21 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Jinyu Lu's work include Hippo pathway signaling and YAP/TAZ (4 papers), MRI in cancer diagnosis (3 papers) and RNA Research and Splicing (3 papers). Jinyu Lu is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (4 papers), MRI in cancer diagnosis (3 papers) and RNA Research and Splicing (3 papers). Jinyu Lu collaborates with scholars based in United States, China and Switzerland. Jinyu Lu's co-authors include Robert J. Schneider, Navid Sadri, Bedabrata Sarkar, Michelle L. Badura, Tian Xu, Peter Lichtlen, David Ron, Scott G. Clark, John C. Sok and Marcella A. Calfon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jinyu Lu

17 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinyu Lu United States 11 514 122 111 69 65 21 670
Christopher von Roretz Canada 10 548 1.1× 77 0.6× 143 1.3× 38 0.6× 41 0.6× 10 623
Chuanbing Zhu China 17 460 0.9× 71 0.6× 93 0.8× 36 0.5× 58 0.9× 32 602
Clare Dempsey United Kingdom 10 334 0.6× 96 0.8× 118 1.1× 129 1.9× 77 1.2× 15 592
Quanyi Zhao China 14 439 0.9× 192 1.6× 146 1.3× 37 0.5× 52 0.8× 26 649
Flávia Raquel Gonçalves Carneiro Brazil 8 291 0.6× 95 0.8× 46 0.4× 57 0.8× 48 0.7× 15 411
Johanna Schott Germany 12 671 1.3× 155 1.3× 210 1.9× 26 0.4× 68 1.0× 19 809
Dania Haddad Kuwait 15 295 0.6× 103 0.8× 57 0.5× 66 1.0× 59 0.9× 32 564
Louis R. Ghanem United States 12 435 0.8× 68 0.6× 56 0.5× 74 1.1× 127 2.0× 27 642
Hong Xin China 13 434 0.8× 97 0.8× 157 1.4× 42 0.6× 90 1.4× 22 622
Henry Pratt United States 12 419 0.8× 55 0.5× 74 0.7× 67 1.0× 39 0.6× 24 532

Countries citing papers authored by Jinyu Lu

Since Specialization
Citations

This map shows the geographic impact of Jinyu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinyu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinyu Lu more than expected).

Fields of papers citing papers by Jinyu Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinyu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinyu Lu. The network helps show where Jinyu Lu may publish in the future.

Co-authorship network of co-authors of Jinyu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinyu Lu. A scholar is included among the top collaborators of Jinyu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinyu Lu. Jinyu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Boutet, Marie, Zheng Zhang, Marcelo Coutinho de Miranda, et al.. (2025). Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells. Immunity. 58(8). 2035–2053.e9. 2 indexed citations
4.
Hou, June Y., Wei Hou, Susan Fineberg, et al.. (2025). COVID-19 pandemic interruption of breast cancer screening is linked to clinical upstaging at presentation: the roles of demographics, socioeconomic status and unmet social needs. Breast Cancer Research and Treatment. 212(2). 205–216. 1 indexed citations
6.
Lu, Jinyu, et al.. (2022). The landscape of systemic therapy for early stage triple-negative breast cancer. Expert Opinion on Pharmacotherapy. 23(11). 1291–1303. 7 indexed citations
7.
Duong, Timothy Q., et al.. (2022). Internal mammary lymph nodal response to neoadjuvant chemotherapy on imaging and breast cancer prognosis. Annals of Medicine and Surgery. 84. 104900–104900.
8.
Liu, Peng, Wenyan Xu, Sha Song, et al.. (2022). Ptp61F integrates Hippo, TOR, and actomyosin pathways to control three-dimensional organ size. Cell Reports. 41(7). 111640–111640. 4 indexed citations
9.
Lo, Yungtai, et al.. (2022). EZH2 Protein Expression in Estrogen Receptor Positive Invasive Breast Cancer Treated With Neoadjuvant Endocrine Therapy: An Exploratory Study of Association With Tumor Response. Applied immunohistochemistry & molecular morphology. 30(9). 614–622. 1 indexed citations
10.
Dong, Yongli, et al.. (2021). Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance. Communications Biology. 4(1). 374–374. 13 indexed citations
11.
Lu, Jinyu, et al.. (2021). Misshapen Disruption Cooperates with RasV12 to Drive Tumorigenesis. Cells. 10(4). 894–894. 5 indexed citations
12.
Musher, Benjamin, Brandon G. Smaglo, Wasif M. Abidi, et al.. (2020). A phase I/II study combining a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus and nab-paclitaxel/gemcitabine chemotherapy in advanced pancreatic cancer: An interim report.. Journal of Clinical Oncology. 38(4_suppl). 716–716. 10 indexed citations
13.
Ma, Xianjue, et al.. (2017). PP6 Disruption Synergizes with Oncogenic Ras to Promote JNK-Dependent Tumor Growth and Invasion. Cell Reports. 19(13). 2657–2664. 29 indexed citations
14.
Sadri, Navid, Jinyu Lu, Michelle L. Badura, & Robert J. Schneider. (2010). AUF1 is involved in splenic follicular B cell maintenance. BMC Immunology. 11(1). 1–1. 72 indexed citations
15.
Sun, Guizhi, et al.. (2010). The molecular mechanisms of Yang Wei Kang Liu powder on anticancer and reducing chemotherapy side-effect in combination with chemotherapy. The Chinese-German Journal of Clinical Oncology. 9(5). 287–291.
16.
Lu, Jinyu, Navid Sadri, & Robert J. Schneider. (2006). Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes & Development. 20(22). 3174–3184. 166 indexed citations
17.
18.
Lu, Jinyu & Robert J. Schneider. (2004). Tissue Distribution of AU-rich mRNA-binding Proteins Involved in Regulation of mRNA Decay. Journal of Biological Chemistry. 279(13). 12974–12979. 110 indexed citations
19.
Sarkar, Bedabrata, Jinyu Lu, & Robert J. Schneider. (2003). Nuclear Import and Export Functions in the Different Isoforms of the AUF1/Heterogeneous Nuclear Ribonucleoprotein Protein Family. Journal of Biological Chemistry. 278(23). 20700–20707. 101 indexed citations
20.
Sok, John C., Marcella A. Calfon, Jinyu Lu, et al.. (2001). Arsenite-inducible RNA-associated protein (AIRAP) protects cells from arsenite toxicity. Cell Stress and Chaperones. 6(1). 6–6. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026